Background: Differences between paclitaxel-eluting stents (PES) and sirolimus-eluting stent (SES) in neointimal proliferation under strictly matched conditions remain to be clarified by optical coherence tomography (OCT).
aclitaxel-eluting stents (PES) and sirolimus-eluting stents (SES) more effectively decrease angiographic restenosis and target lesion revascularization than bare-metal stents. 1- 9 The safety of these drug-eluting stents (DES), however, is currently under debate with regard to their potential for late stent thrombosis (LST), a life-threatening complication, especially after discontinuation of dual antiplatelet therapy. Hypersensitivity reactions to the polymer used in DES, delayed endothelialization of the stents, and discontinuation of dual antiplatelet therapy are thought to be potential risk factors for DES stent thrombosis. 10-14 Thus, discrimination of DES in terms of efficacy and safety has emerged as an important issue in the DES era.
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Although clinical outcomes, such as target lesion revascularization, adverse cardiac events, stent thrombosis, and mortality, are similar between SES and PES, 15 several reports suggest that the extent and pattern of neointimal proliferation differ between them. [16] [17] [18] [19] [20] In those studies, however, intravascular ultrasound (IVUS) or quantitative angiography was used without a pure matched comparison to evaluate neointimal growth after DES implantation. The axial resolution of optical coherence tomography (OCT: 10-20 μm) is superior to that of IVUS (100-150 μm). The distribution of neointimal coverage and neointimal thickness (NIT) can be evaluated by OCT in the order of micrometers. 21 In the present study, using OCT in the chronic stage, we MIYOSHI N et al.
compared a single SES and PES implanted in a single coronary artery with a long diffuse lesion and with stent placement randomized to a proximal or distal location.
Methods

Patients and Procedures
Between May and December 2007, 27 patients who had a long diffuse obstruction in a single coronary artery were each implanted with a PES (Taxus Express TM stent, Boston Scientific Corp, Natick, MA, USA) and a SES (Cypher TM stent, Cordis/Johnson & Johnson, Miami Lakes, FL, USA). The site of each stent implantation, proximal or distal, was randomly assigned. Prior to DES implantation, IVUS was performed using a 2.9Fr 20-MHz IVUS catheter (EagleEye TM ; Volcano Therapeutics, Inc, Rancho Cordova, CA, USA) with an automatic pullback device at 0.5 mm/s to measure the vessel size and identify the location of the plaque. After stent implantation, IVUS was again performed to ensure that the DES was fully expanded. If not, additional high-pressure balloon expansion was repeated until IVUS indicated that the DES was well-expanded. In 12 cases, the PES was deployed at the proximal site and the SES at the distal site (P-S group), and in 15 cases, the SES was deployed at the proximal site and the PES at the distal site (S-P group). After 6 months, all patients underwent follow-up angiography and OCT examination. Oral aspirin 100 mg/day and oral ticlopidine 200 mg/day or clopidogrel 75 mg/day were prescribed to all patients at least 3 days prior to percutaneous coronary intervention and continued for 6 months. This study was approved by the Ethical Committee of Kobe University and all the patients enrolled in this study provided written informed consent.
OCT Examination
OCT images were obtained as previously described. 21, 22 Briefly, an OCT imaging probe (ImageWire TM , LightLab Imaging, Westford, MA, USA) was inserted through the over-the-wire lumen of the occlusion balloon (Helios TM , LightLab Imaging). To clear blood from the imaging site, the proximal occlusion balloon was inflated to 0.5 atm and lactated Ringer's solution was infused into the coronary artery from the distal tip of the occlusion balloon at 0.5 ml/s. The entire length of the stent was imaged with an automatic pullback device moving at 1 mm/s and OCT imaging clearly visualized the stent's cross-section.
OCT Analysis
The OCT images were analyzed by 2 independent observers using a proprietary off-line review system (LightLab Imaging). All OCT cross-sectional image frames were evaluated to detect thrombi and to inspect whether stent struts were covered with neointima and apposed to the vessel wall. In every 15th frame (1 mm), we evaluated each stent strut condition for classification into 1 of 6 categories: (1) well-apposed to the vessel wall with neointimal coverage overlaying the strut, (2) well-apposed to the vessel wall without neointimal coverage, (3) malapposed to the vessel wall with neointimal coverage, (4) malapposed to the vessel wall without neointimal coverage, (5) orifice branch site with neointima, (6) orifice branch site without neointima. A malapposed strut was defined as a distance of more than 170 μm between the center reflection of the strut to the vessel wall. This criterion was determined by adding the actual strut thickness and polymer thickness to the OCT resolution limit (130 μm + 14 μm + 20 μm in PES; 140 μm +10 μm + 20 μm in SES). If neointimal coverage of the strut was observed, its thickness was measured from the neointimal surface to the center 
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reflection of the strut. 23 To evaluate the radial unevenness of NIT (RUNIT), the difference between the maximum and minimum NIT was calculated for each cross-section and to evaluate the longitudinal axis unevenness of NIT (LUNIT), the difference between the maximum NIT and minimum NIT in the longitudinal axis was calculated for each stent. In addition, frequency of thrombus formation and low-density spots surrounding the strut were recorded. A thrombus was defined as a mass protruding beyond the stent strut into the lumen with significant attenuation behind the mass. 24-26 A low-density spot was defined as a contrasting area of lower intensity than the adjacent surrounding neointimal tissue.
Representative images of neointimal coverage in PES and SES, struts with a side-branch orifice, malapposed struts, NIT measurement, and a peri-strut low-intensity mural thrombus are shown in Figure 1 .
Statistical Analysis
Qualitative data are presented as frequencies and quantitative data are shown as medians (25th, 75th percentiles) or mean values ± SD, as indicated. Classification data of 2 groups were compared using the chi-square test. A statistical difference in NIT was determined by Mann-Whitney U test. Other quantitative data were analyzed using an unpaired t-test. A 2-sided P-value of less than 0.05 was considered statistically significant. Statistical evaluation was performed with dedicated software (MedCalc version 10.3.1.0; MedCalc Software, Mariakerke, Belgium). (Figure 3) . RUNIT was larger in the PES group than in the SES group: 206±88 vs 131±57 μm (P<0.001), and LUNIT was also larger in the PES group than in the SES group: 607±243 vs 400±185 μm (P<0.001). The distribution of NIT on the struts is shown in MIYOSHI N et al.
Results
Figure 4.
Struts with low-intensity spots were significantly more frequent in the PES group than in the SES group (30.9% vs 17.0%, P=0.001). We detected a mural thrombus in 9 stents of PES and 7 stents of SES (33% vs 26%, P=0.77).
Discussion
This is the first report of using OCT examination to compare PES and SES implanted under strictly matched conditions. Neointimal non-coverage and malapposition were significantly less frequently observed with PES than with SES. NIT was significantly greater in PES than in SES, regardless . Neointimal thickness (NIT) distribution in PES and SES. The peak frequency of the NIT distribution was 40-60 μm for both PES and SES. Frequency at 0-60 μm was greater for SES than PES, and at 60-80 μm, the frequency was similar between SES and PES. PES, paclitaxel-eluting stents; SES, sirolimus-eluting stents.
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of the stent's location, proximal or distal. Compared with SES, the larger RUNIT and LUNIT of PES suggest nonuniformity of neointimal proliferation with PES. The median NIT of SES (50 μm [25th: 20 μm; 75th: 140 μm]) in this study was close to that observed in our previous study (52.5 μm [25th: 28.0 μm; 75th: 147.6 μm]), 21 suggesting good reproducibility of the OCT findings for DES follow-up. The NIT of 90 μm in PES was larger than that in SES. For uniform neointimal suppression, distribution of an effective dose concentration to the vessel is crucial. Optimization of drug distribution requires symmetric expansion of the stent for homogeneous distribution. 27 The closed cell of the SES maintains a relatively regular strut distribution despite expansion in various anatomic situations and appears to provide more regular and predictable drug delivery. The PES, however, has an open cell design and a more uneven strut distribution, especially when implanted into a tortuous lesion. 28 This uneven strut distribution may result in uneven drug delivery. In addition, the narrow therapeutic window of paclitaxel may contribute to heterogeneous neointimal growth after PES implantation. 29 Farb et al found a paclitaxel dose-dependent neointimal suppression and subsequent increase in vessel wall toxicity in a porcine coronary model. 30 Sirolimus, on the other hand, uniformly suppresses neointimal proliferation after vascular injury at a relatively wide range of therapeutic doses. 31 These mechanisms explain the non-uniform neointimal proliferation in PES, which may contribute to the clinically different pattern and frequency of restenosis with PES compared with SES. 18 In this study, we found mural thrombi in approximately 30% of both PES and SES (PES: 33%, SES: 26%). We previously reported that a mural thrombus in SES is not rare and that the presence of a mural thrombus is related to a longer stent, asymmetric stent expansion, increased number of uncovered struts, and unevenness of the NIT. 26 On the other hand, Murakami et al reported that the presence of thrombus in first-generation DES was not related to advanced neointimal growth. 32 Although it could be hypothesized that the higher frequency of uncovered SES, and the NIT unevenness in PES relate to the formation of mural thrombus, further investigation is necessary to understand thrombus formation. Also, whether the next generation of DES will reduce the incidence of mural thrombus remains to be clarified.
Based on pathologic studies, incomplete neointimal stent coverage is the most important morphometric predictor of LST because it is the most powerful surrogate indicator of endothelialization. 33, 34 None of the cases of mural thrombus in our study subjects, however, resulted in LST. We speculate that thrombosis with complete vessel obstruction requires specific factors, such as blood flow stasis or increased coagulability, in addition to the thrombogenicity of uncovered struts.
According to our results, PES had a higher frequency of peri-strut low-intensity areas than SES. Gonzalo et al 35 showed the OCT pattern of restenotic tissue after DES implantation. In their report, restenotic tissue backscatter was divided into high or low (high: the majority of the tissue showed high backscatter and appeared bright; low: the majority of the tissue showed low backscatter and appeared dark or black). Also, they categorized the tissue structure as homogeneous, heterogeneous, or layered. Low backscatter was observed even in non-restenotic, thin neointimal tissue surrounding stent struts, hence in both restenotic and nonrestenotic tissue, low backscatter tissue surrounding stent struts was determined as a low-density spot in that study.
Upon histological analysis, fibrin was mainly observed at the "black spot site" (we call it a "low-density spot") on the corresponding OCT image. Hyaluronic acid and proteoglycan were also observed, and, in small amounts, neutrophil and macrophage infiltration. The "black spots" seem to represent the process of fibrin resolution. 36 Lüscher et al 37 reported that PES showed early fibrin deposition around stent struts, which persisted for up to 8 months as a sign of delayed healing. In contrast, SES showed a predominance of inflammatory cells, including giant cell formation, at early time points (1 and 3 months), and fibrin deposition was stronger at 8 months. Both circumferential and radial drug concentration gradients are greatest near the struts and decay rapidly before increasing again near the perivascular space. 27 This high drug concentration may result in peri-strut inflammation. Structures with delayed healing might be imaged as peri-strut low-intensity areas by OCT. The difference in the frequency of peri-strut low-intensity areas suggests a different time course of vascular healing, which may be caused by the pharmacologic differences between paclitaxel and sirolimus. 38 This mechanism may also underlie the difference between PES and SES in NIT.
Struts at the side-ranch orifice site were evaluated separately, because they were not apposed to the vessel wall permanently and the flow at the side-branch orifice should be different from that at the vessel wall site. Indeed, more than 50% of both types of struts at the side-branch orifice site were not covered with neointima.
Although this is a simple observational study, we set up a strictly matched condition between PES and SES. This study using OCT demonstrated clear morphological differences between PES and SES, such as the frequency of uncovered struts, median value and evenness of NIT, and frequency of peri-strut low-intensity areas or mural thrombus. This knowledge could be helpful in understanding the differences in neointimal proliferation among DES. These OCT data will be the basic data when comparing the next generation DES.
Study Limitations
First, even though we evaluated the stents in a strictly matched manner, our findings were based on a relatively small number of subjects. Second, because OCT cannot diagnose tissue character, we could not discriminate between neointima and the smooth surface of a white thrombus. A higher frequency of mural thrombus is therefore possible. Third, the only PES evaluated was the Taxus Express™ stent. The next-generation PES, Taxus Liberte™ stent, which has a denser stent distribution, may produce a better outcome with suppressed and uniform neointimal proliferation.
Conclusion
Our OCT findings indicate that PES (Taxus Express™) have a non-uniform and larger NIT with fewer uncovered struts, and more frequent peri-strut low-intensity areas than SES.
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